Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Zhirui Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9547-9074; OpenAlex author ID A5031875987. Sources: OpenAlex.

Their work

Papers
23 (first author 10, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 6 papers · 2022: 6 papers · 2023: 2 papers · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 23

  1. Correction: Genome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alte… Co-author DOI 10.1007/s00535-026-02521-2↗
  2. Correction: Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. First author DOI 10.1038/s41420-025-02871-5↗
  3. Targeted inhibition of OTUD7B enhances therapeutic sensitivity in KRAS- mutant pancreatic ductal adenocarcinoma by promoting ubiquitination of DHODH First author DOI 10.21203/rs.3.rs-11197976/v1↗
  4. aGenome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alternative spl… Co-author DOI 10.1007/s00535-025-02272-6↗
  5. TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4. Co-author DOI 10.1016/j.drup.2024.101171↗
  6. Schizandrin A suppressed pancreatic cancer proliferation and cancer associated fibroblast activation via inhibiting the COX-2/ALOX5 shunting Co-author DOI 10.1101/2024.10.09.24315180↗
  7. Genome-scale activation screen reveals lncRNA HNF1A-AS1 as a novel therapeutic target for pancreatic cancer metastasis Co-author DOI 10.21203/rs.3.rs-5388928/v1↗
  8. Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2. Co-author DOI 10.1111/jcmm.17852↗
  9. 5'-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis. First author DOI 10.3390/biom13101513↗
  10. E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2. Co-author DOI 10.1007/s12032-022-01715-x↗
  11. Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. Co-author DOI 10.1038/s41419-022-04677-0↗
  12. Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. First author DOI 10.1038/s41420-022-01008-2↗
  13. Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2. Co-author DOI 10.1080/21655979.2022.2054205↗
  14. Transformer 2 alpha homolog is a downstream gene of hypoxia-inducible factor 1 subunit alpha and is involved in the progression of pancreatic cancer. Co-author DOI 10.1080/21655979.2022.2079243↗
  15. Sinapine Thiocyanate Inhibits the Proliferation and Mobility of Pancreatic Cancer Cells by Up-Regulating GADD45A. First author DOI 10.7150/jca.65212↗
  16. YEATS2 is a target of HIF1α and promotes pancreatic cancer cell proliferation and migration. Co-author DOI 10.1002/jcp.29995↗
  17. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway. First author DOI 10.18632/aging.202569↗
  18. Hypoxia-related gene FUT11 promoted pancreatic cancer progression via maintaining the stabilization of PDK1 First author DOI 10.21203/rs.3.rs-152464/v3↗
  19. Hypoxia-Related Gene FUT11 Promoted Pancreatic Cancer Progression Via Maintaining The Stabilization of PDK1 First author DOI 10.21203/rs.3.rs-153965/v1↗
  20. Hypoxia-Related Gene FUT11 Promotes Pancreatic Cancer Progression by Maintaining the Stability of PDK1. First author DOI 10.3389/fonc.2021.675991↗
  21. miRNA‑7515 suppresses pancreatic cancer cell proliferation, migration and invasion via downregulating IGF‑1 expression. First author DOI 10.3892/or.2021.8151↗
  22. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis. Co-author DOI 10.3892/or.2020.7480↗
  23. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway. Co-author DOI 10.1186/s13046-019-1388-4↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shan Lei · 21 shared papers, 2019–2026 · strength 4.06
  2. Wenpeng Cao · 16 shared papers, 2021–2026 · strength 3.29
  3. Zhiwei He · 8 shared papers, 2019–2025 · strength 1.39
  4. Tengxiang Chen · 7 shared papers, 2019–2025 · strength 1.22
  5. Zhangxia Ren · 2 shared papers, 2022–2026 · strength 0.48
  6. Zijiang Yu · 3 shared papers, 2021 · strength 0.39
  7. Peng Chen · 1 shared paper, 2026 · strength 0.32
  8. Tengxiang Chen · 1 shared paper, 2026 · strength 0.29
  9. Dijie Zheng · 1 shared paper, 2025 · strength 0.28
  10. Futang Li · 1 shared paper, 2025 · strength 0.28
  11. Changhao Wu · 1 shared paper, 2025 · strength 0.28
  12. Chao Yu · 1 shared paper, 2025 · strength 0.28
  13. Jianxin Jiang · 2 shared papers, 2019–2021 · strength 0.28
  14. Lirui Tang · 1 shared paper, 2026 · strength 0.26
  15. Yiran Chen · 1 shared paper, 2026 · strength 0.26
  16. Kun Cai · 1 shared paper, 2022 · strength 0.19
  17. Xiaowu Li · 1 shared paper, 2022 · strength 0.19
  18. Jie Wang · 1 shared paper, 2022 · strength 0.16
  19. Qianfan Liu · 1 shared paper, 2022 · strength 0.16
  20. Peng Chen · 1 shared paper, 2022 · strength 0.16
  21. Haitao Zhu · 1 shared paper, 2022 · strength 0.16
  22. Wenfeng Yu · 1 shared paper, 2022 · strength 0.16
  23. Jingya Wang · 1 shared paper, 2022 · strength 0.15
  24. Junbin Han · 1 shared paper, 2022 · strength 0.15
  25. Bing Guo · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.